NutraSift: The nutraceutical innovation podcast

Andrographis: The 'King of Bitters' that Thailand used as a COVID treatment

5 min · 22 de may de 2026
Portada del episodio Andrographis: The 'King of Bitters' that Thailand used as a COVID treatment

Descripción

In 2021, Thailand's Department of Thai Traditional and Alternative Medicine approved andrographis (Fah Talai Jone) for early-stage COVID-19 treatment. Andrographolide covalently binds to the p50 subunit of NF-kB one of the most specific and irreversible anti-inflammatory mechanisms known in natural products. This isn't weak binding or allosteric modulation. It's a covalent modification. That's drug-level mechanism specificity in a plant extract that costs pennies. Publications of interest: https://pubmed.ncbi.nlm.nih.gov/15356172/ https://pmc.ncbi.nlm.nih.gov/articles/PMC11246112/ https://pmc.ncbi.nlm.nih.gov/articles/PMC12351123/

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y únete a la comunidad de NutraSift: The nutraceutical innovation podcast!

Empezar

2 meses por 1 €

Después 4,99 € / mes · Cancela cuando quieras.

  • Podcasts exclusivos
  • 20 horas de audiolibros / mes
  • Podcast gratuitos

Todos los episodios

77 episodios